Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients
Titel:
Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients
Auteur:
Reddy, B.K.M. Lokesh, V. Vidyasagar, M.S. Shenoy, K. Babu, K.G. Shenoy, A. Naveen, T. Joseph, Bindhu Bonanthaya, R. Nanjundappa, Bapsy, P.P. Loknatha, Shetty, Jayarama Prasad, Krishna Tanvir Pasha, C.R.